News

The Pancreatic Cancer Therapy Market is one of the rapidly expanding sectors within the global oncology industry. Pancreatic cancer is known for its aggressive nature, with a low survival rate, making ...
The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...
Startup Gameto has developed a technique for maturing eggs outside the body that’s showing promise at helping patients get ...
GSK has continued to flesh out its neuroscience strategy with a 2 billion pound sterling ($2.5 billion) deal to use a South ...
Expanding Demand Across Hormonal Health: Market Outlook The Europe Hormone Replacement Therapy (HRT) market continues on a ...
The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...
The global point of care blood testing devices market is on a rapid upward trajectory, with projections indicating a remarkable expansion to an estimated value of USD 49,973.6 million by 2032. This ...
Short-term GHRT was effective and safe without increased risk for cancers among real-world adults with growth hormone deficiency.
Beijing-based feed group Dabeinong said on Thursday that three genetically modified soybean varieties developed by its biotech unit have been approved for planting by Uruguay's authorities.
Family-controlled Spanish pharma company Esteve has signed a license and supply agreement with Eton Pharmaceuticals (Nasdaq: ...
Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...
Genomics encompasses the study of a complete set of genes, their work process, and their way of interacting with each other and the environment. While it incorporates elements of genetics, the primary ...